Author: admin

  • AMD Starts Enabling Zen 6 “znver6” Compiler Support In GCC

    AMD Starts Enabling Zen 6 “znver6” Compiler Support In GCC

    Making for a bit more exciting weekend is that minutes ago AMD has posted their first patch for enabling Zen 6 processor support within the GNU Compiler Collection (GCC) for -march=znver6 targeting.

    Last month AMD posted their GNU Binutils…

    Continue Reading

  • Argan (AGX) Valuation Check After a Sharp Pullback in the Share Price

    Argan (AGX) Valuation Check After a Sharp Pullback in the Share Price

    Argan (AGX) has pulled back sharply this week, slipping about 12% in a single session and over 20% in the past week, even though the shares remain significantly higher over the past three months.

    See our latest analysis for Argan.

    Even after this week’s slide, Argan’s 1 year total shareholder return of around 115% and enormous 3 year total shareholder return appear to signal strong underlying momentum. At the same time, the recent pullback suggests investors are reassessing short term risk after a powerful run.

    If Argan’s surge has you rethinking your watchlist, it could be a smart moment to explore fast growing stocks with high insider ownership to research other fast moving opportunities with strong insider conviction.

    With Argan still trading below analyst targets and implying a hefty intrinsic discount, investors now face a pivotal question: Is the stock still undervalued, or is the market already pricing in years of future growth?

    With Argan closing around $313.70 versus a narrative fair value of roughly $295.75, the most followed view sees recent strength pushing into premium territory.

    Record backlog and continued project wins across gas, renewables, water treatment, and recycling plants provide multi-year revenue visibility, indicating potential for increased operating leverage and higher gross margins as larger projects are executed successfully.

    Read the complete narrative.

    Curious how multi year double digit expansion, moderating margins, and a richer future earnings multiple still add up to upside in this framework? The growth math behind that conclusion is not what most investors would expect from a construction contractor. Want to see which long term revenue and profit assumptions quietly justify paying up from here? Explore the full narrative to unpack the projections that support this valuation view.

    Result: Fair Value of $295.75 (OVERVALUED)

    Have a read of the narrative in full and understand what’s behind the forecasts.

    However, the thesis leans heavily on large gas projects, so any delays, cancellations, or faster than expected decarbonization could quickly pressure earnings.

    Find out about the key risks to this Argan narrative.

    Our SWS DCF model suggests Argan is trading about 42.7% below its fair value of $547.36, a sharp contrast to the narrative view that sees the stock as slightly overvalued. If cash flows point one way and sentiment another, which signal do you trust?

    Look into how the SWS DCF model arrives at its fair value.

    AGX Discounted Cash Flow as at Dec 2025

    Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Argan for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 906 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match – so you never miss a potential opportunity.

    If you see the story differently or want to dig into the numbers yourself, you can build a custom view in minutes: Do it your way.

    A great starting point for your Argan research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.

    Before the market’s next move leaves you catching up, put Simply Wall Street’s Screener to work and uncover focused opportunities that match your exact investing style.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

    Companies discussed in this article include AGX.

    Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

    Continue Reading

  • The stage is set for a much better Motorola Razr Ultra in 2026, and I can’t wait to see how it improves on arguably the best flip phone of 2025. Here’s how the Galaxy Z Flip 7 and current smartphone trends can literally help shape the next Razr

    The stage is set for a much better Motorola Razr Ultra in 2026, and I can’t wait to see how it improves on arguably the best flip phone of 2025. Here’s how the Galaxy Z Flip 7 and current smartphone trends can literally help shape the next Razr

    When the Motorola Razr Plus 2023 was announced, it was the first time in a long time that I was truly excited for a new smartphone. Sure, it wasn’t the first Razr smartphone, and the Galaxy Z Flip was already well-established at that point, but…

    Continue Reading

  • Race Identified as Prognostic Indicator in Black Patients With AML

    Race Identified as Prognostic Indicator in Black Patients With AML

    A 30-year retrospective analysis of clinical trials involving patients with acute myeloid leukemia (AML) receiving intensive chemotherapy demonstrated that Black race is an independent prognostic factor for lower survival outcomes in patients,…

    Continue Reading

  • As Path of Exile 2: The Last of the Druids gears up for release next week, its devs , sort of, delay its 1.0 release date

    As Path of Exile 2: The Last of the Druids gears up for release next week, its devs , sort of, delay its 1.0 release date


    A new trailer for the next Path of Exile 2 update, The Last of the Druids, was shared earlier this week, showing off all the cool things you can do in it! Which are mostly relegated to turning into animals, but in my eyes that…

    Continue Reading

  • How flu viruses infect human cells

    How flu viruses infect human cells